Đang chuẩn bị liên kết để tải về tài liệu:
Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer: Analysis from the German StuDoQ|Rectalcarcinoma registry

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Preoperative chemoradiotherapy is the recommended standard of care for patients with local advanced rectal cancer. However, it remains unclear, whether a prolonged time interval to surgery results in an increased perioperative morbidity, reduced TME quality or better pathological response. | Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer Analysis from the German StuDoQ Rectalcarcinoma registry

TÀI LIỆU LIÊN QUAN

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy

Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: Retrospective case series

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.